ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
81.77
-0.97 (-1.17%)
At close: Dec 5, 2025, 4:00 PM EST
82.51
+0.74 (0.90%)
After-hours: Dec 5, 2025, 5:47 PM EST
ANI Pharmaceuticals Revenue
ANI Pharmaceuticals had revenue of $227.81M in the quarter ending September 30, 2025, with 53.58% growth. This brings the company's revenue in the last twelve months to $826.88M, up 48.87% year-over-year. In the year 2024, ANI Pharmaceuticals had annual revenue of $614.38M with 26.20% growth.
Revenue (ttm)
$826.88M
Revenue Growth
+48.87%
P/S Ratio
1.95
Revenue / Employee
$921,828
Employees
897
Market Cap
1.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 614.38M | 127.56M | 26.20% |
| Dec 31, 2023 | 486.82M | 170.43M | 53.87% |
| Dec 31, 2022 | 316.39M | 100.25M | 46.38% |
| Dec 31, 2021 | 216.14M | 7.66M | 3.67% |
| Dec 31, 2020 | 208.48M | 1.93M | 0.93% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ANIP News
- 3 days ago - ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina Franchise - GlobeNewsWire
- 4 days ago - ANI Pharmaceuticals Announces Board Transition - GlobeNewsWire
- 10 days ago - ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 24 days ago - ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – London - GlobeNewsWire
- 4 weeks ago - ANI Pharmaceuticals, Inc. (ANIP) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 Guidance - GlobeNewsWire
- 5 weeks ago - ANI Pharmaceuticals: Strong Buy On Rare Disease Growth, Record Of Beating Estimates - Seeking Alpha
- 6 weeks ago - ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET - GlobeNewsWire